4.7 Article

BERTMHC: improved MHC-peptide class II interaction prediction with transformer and multiple instance learning

向作者/读者索取更多资源

This study introduces a transformer neural network model that leverages self-supervised pretraining and a multiple instance learning framework to improve the prediction performance of peptide-MHC binding and presentation. The combination of pretraining and the novel MIL approach outperforms state-of-the-art models for both tasks.
Motivation: Increasingly comprehensive characterization of cancer-associated genetic alterations has paved the way for the development of highly specific therapeutic vaccines. Predicting precisely the binding and presentation of peptides to major histocompatibility complex (MHC) alleles is an important step toward such therapies. Recent data suggest that presentation of both class I and II epitopes are critical for the induction of a sustained effective immune response. However, the prediction performance for MHC class II has been limited compared to class I. Results: We present a transformer neural network model which leverages self-supervised pretraining from a large corpus of protein sequences. We also propose a multiple instance learning (MIL) framework to deconvolve mass spectrometry data where multiple potential MHC alleles may have presented each peptide. We show that pretraining boosted the performance for these tasks. Combining pretraining and the novel MIL approach, our model outperforms state-of-the-art models based on peptide and MHC sequence only for both binding and cell surface presentation predictions.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemistry & Molecular Biology

Cis-regulatory elements explain most of the mRNA stability variation across genes in yeast

Jun Cheng, Kerstin C. Maier, Ziga Avsec, Petra Rus, Julien Gagneur

Article Biotechnology & Applied Microbiology

Sequential administration of MVA-based vaccines and PD-1/PD-L1-blocking antibodies confers measurable benefits on tumor growth and survival: Preclinical studies with MVA-Gal and MVA-MUC1 (TG4010) in a murine tumor model

Christelle Remy-Ziller, Christine Thioudellet, Julie Hortelano, Murielle Gantzer, Virginie Nourtier, Marie-Christine Claudepierre, Benoit Sansas, Xavier Preville, Kaidre Bendjama, Eric Quemeneur, Karola Rittner

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)

Meeting Abstract Oncology

Single intravenous preoperative administration of the oncolytic virus Pexa-Vec to prime anti-tumor immunity.

Alan Anthoney, Adel Samson, Emma West, Samantha Jane Turnbull, Karen Scott, Emma Tidswell, Jennifer Kingston, Michelle Johnpulle, Samantha Noutch, Kaidre Bendjama, Michel Homerin, Nicolas Stojkowitz, Giles Toogood, Chris Twelves, Christy Ralph, Alan Melcher, Fiona Jane Collinson

JOURNAL OF CLINICAL ONCOLOGY (2018)

Article Genetics & Heredity

CAGI 5 splicing challenge: Improved exon skipping and intron retention predictions with MMSplice

Jun Cheng, Muhammed Hasan Celik, Thi Yen Duong Nguyen, Ziga Avsec, Julien Gagneur

HUMAN MUTATION (2019)

Letter Biotechnology & Applied Microbiology

The Kipoi repository accelerates community exchange and reuse of predictive models for genomics

Ziga Avsec, Roman Kreuzhuber, Johnny Israeli, Nancy Xu, Jun Cheng, Avanti Shrikumar, Abhimanyu Banerjee, Daniel S. Kim, Thorsten Beier, Lara Urban, Anshul Kundaje, Oliver Stegle, Julien Gagneur

NATURE BIOTECHNOLOGY (2019)

Article Genetics & Heredity

Assessing predictions of the impact of variants on splicing in CAGI5

Stephen M. Mount, Ziga Avsec, Liran Carmel, Rita Casadio, Muhammed Hasan Celik, Ken Chen, Jun Cheng, Noa E. Cohen, William G. Fairbrother, Tzila Fenesh, Julien Gagneur, Valer Gotea, Tamar Holzer, Chiao-Feng Lin, Pier Luigi Martelli, Tatsuhiko Naito, Thi Yen Duong Nguyen, Castrense Savojardo, Ron Unger, Robert Warig, Yuedong Yang, Huiying Zhao

HUMAN MUTATION (2019)

Article Biotechnology & Applied Microbiology

Safety and immunogenicity of the therapeutic vaccine TG1050 in chronic hepatitis B patients: a phase 1b placebo-controlled trial

Fabien Zoulim, Claire Fournier, Francois Habersetzer, Martin Sprinzl, Stanislas Pol, Carla S. Coffin, Vincent Leroy, Mang Ma, Heiner Wedemeyer, Ansgar W. Lohse, Robert Thimme, Karine Lugardon, Perrine Martin, Berangere Bastien, Benoit Sansas, Nathalie Adda, Celine Halluard, Kaidre Bendjama, Maud Brandely, Genevieve Inchauspe

HUMAN VACCINES & IMMUNOTHERAPEUTICS (2020)

Article Oncology

Correlation of HPV16 Gene Status and Gene Expression With Antibody Seropositivity and TIL Status in OPSCC

Adrian von Witzleben, Eve Currall, Oliver Wood, Lindsey Chudley, Oluyemisi Akinyegun, Jaya Thomas, Kaidre Bendjama, Gareth J. Thomas, Peter S. Friedmann, Emma V. King, Simon Laban, Christian H. Ottensmeier

Summary: This study investigated the relationship between HPV16 gene expression and adaptive immune responses, revealing that the expression of the E7 gene was correlated with antibody levels in the blood. Patients with high levels of anti-E2 IgG antibodies demonstrated better overall survival.

FRONTIERS IN ONCOLOGY (2021)

Article Oncology

Targeting the tumor mutanome for personalized vaccination in a TMB low non-small cell lung cancer

Katy McCann, Adrian von Witzleben, Jaya Thomas, Chuan Wang, Oliver Wood, Divya Singh, Konstantinos Boukas, Kaidre Bendjama, Nathalie Silvestre, Finn Cilius Nielsen, Gareth Thomas, Tilman Sanchez-Elsner, Jason Greenbaum, Stephen Schoenberger, Bjoern Peters, Pandurangan Vijayanand, Natalia Savelyeva, Christian Ottensmeier

Summary: This study demonstrates the feasibility of efficiently identifying tumor-specific neoantigens and targeting them with vaccination in tumors with a low mutational burden, showing promising potential for successful clinical exploitation.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

Article Immunology

Pseudocowpox virus, a novel vector to enhance the therapeutic efficacy of antitumor vaccination

Rodrigo Nalio Ramos, Caroline Tosch, Fiorella Kotsias, Marie-Christine Claudepierre, Doris Schmitt, Christelle Remy-Ziller, Chantal Hoffmann, Marine Ricordel, Virginie Nourtier, Isabelle Farine, Laurence Laruelle, Julie Hortelano, Clementine Spring-Giusti, Christine Sedlik, Christophe Le Tourneau, Caroline Hoffmann, Nathalie Silvestre, Philippe Erbs, Kaidre Bendjama, Christine Thioudellet, Eric Quemeneur, Eliane Piaggio, Karola Rittner

Summary: This study identifies bovine pseudocowpox virus (PCPV) as a viral vector with strong immune stimulating abilities, capable of activating immune cells and reversing tumor-induced T-cell suppression. Using PCPV encoding the HPV16 E7 protein as a vaccine, significant antigen-specific T-cell responses were induced in experimental tumor-bearing mice, resulting in complete tumor regression. From a translational perspective, PCPV-E7 effectively stimulated IFN-γ production by T cells from tumor-draining lymph nodes of HPV+-infected cancer patients.

CLINICAL & TRANSLATIONAL IMMUNOLOGY (2022)

Article Biotechnology & Applied Microbiology

MTSplice predicts effects of genetic variants on tissue-specific splicing

Jun Cheng, Muhammed Hasan Celik, Anshul Kundaje, Julien Gagneur

Summary: MTSplice is a free and open-source model developed to predict the effects of genetic variants on splicing of cassette exons in 56 human tissues. It outperforms existing models in predicting tissue-specific variations, especially in brain tissues. Furthermore, MTSplice predicts enrichment of autism-associated de novo mutations for variants affecting splicing specifically in the brain.

GENOME BIOLOGY (2021)

Article Biotechnology & Applied Microbiology

MMSplice: modular modeling improves the predictions of genetic variant effects on splicing

Jun Cheng, Thi Yen Duong Nguyen, Kamil J. Cygan, Muhammed Hasan Celik, William G. Fairbrother, Ziga Avsec, Julien Gagneur

GENOME BIOLOGY (2019)

Article Biochemical Research Methods

Modeling positional effects of regulatory sequences with spline transformations increases prediction accuracy of deep neural networks

Ziga Avsec, Mohammadamin Barekatain, Jun Cheng, Julien Gagneur

BIOINFORMATICS (2018)

暂无数据